{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:35:16Z","timestamp":1787740516304,"version":"build-2784847793"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jinorgbio.2026.113359","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:25:53Z","timestamp":1778718353000},"page":"113359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Copper (I) nicotinate complex potentiates chemotherapy-induced apoptosis in HCC-1806 triple negative breast cancer cells: An in vitro study"],"prefix":"10.1016","volume":"282","author":[{"given":"Marihan A.","family":"Helal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Abdel-Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elshahat A.","family":"Toson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2026.113359_bb0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cbi.2018.12.005","article-title":"A new pyrrole based small molecule from Tinospora cordifolia induces apoptosis in MDA-MB-231 breast cancer cells via ROS mediated mitochondrial damage and restoration of p53 activity","volume":"299","author":"Rashmi","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0010","series-title":"A Living Biobank of Triple-Negative Breast Cancer Organoids for Screening Drug Sensitivity","author":"Hong","year":"2019"},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113359_bb0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/mp5008629","article-title":"Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation","volume":"12","author":"Andey","year":"2015","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113359_bb0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mc.22318","article-title":"Quercetin regulates \u03b2-catenin signaling and reduces the migration of triple negative breast cancer","volume":"55","author":"Srinivasan","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.32410","article-title":"Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer","volume":"146","author":"Raninga","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"15","key":"10.1016\/j.jinorgbio.2026.113359_bb0030","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3390\/ijms26157227","article-title":"Prognostic potential of apoptosis-related biomarker expression in triple-negative breast cancers","volume":"26","author":"T\u00f6r\u00f6k","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113359_bb0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/bcr2574","article-title":"Triple-negative breast cancer","volume":"12","author":"Chac\u00f3n","year":"2010","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113359_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058421","article-title":"Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse","volume":"8","author":"Toldo","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1959270","article-title":"Substance P receptor signaling mediates doxorubicin-induced cardiomyocyte apoptosis and triple-negative breast cancer chemoresistance","volume":"2016","author":"Robinson","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113359_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1574892811666160519113731","article-title":"Review of PI3K\/mTOR inhibitors entering clinical trials to treat triple negative breast cancers","volume":"11","author":"Fouqu\u00e9","year":"2016","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ctrv.2017.11.003","article-title":"Triple negative breast cancer: emerging therapeutic modalities and novel combination therapies","volume":"62","author":"Lee","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113359_bb0065","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3892\/or.2016.4799","article-title":"The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo","volume":"36","author":"Yu","year":"2016","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113359_bb0075","first-page":"1711","article-title":"Risk of metabolic complications in patients with solid tumors treated with mTOR inhibitors: meta-analysis","volume":"36","author":"Lew","year":"2016","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-018-0103-z","article-title":"Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma","volume":"7","author":"Johnston","year":"2018","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0085","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2013","journal-title":"Chem. Rev."},{"issue":"32","key":"10.1016\/j.jinorgbio.2026.113359_bb0090","doi-asserted-by":"crossref","first-page":"18359","DOI":"10.1039\/C9RA03130H","article-title":"Induction of cell cycle arrest and apoptosis by copper complex Cu (SBCM) 2 towards oestrogen-receptor positive MCF-7 breast cancer cells","volume":"9","author":"Foo","year":"2019","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0095","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1038\/s41598-024-52952-1","article-title":"Influence of copper (I) nicotinate complex on the Notch1 signaling pathway in triple negative breast cancer cell lines","volume":"14","author":"Abdel-Mohsen","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113359_bb0100","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1002\/jcb.27713","article-title":"Oncostatic treatment effect of triple negative breast cancer cell line with copper (I)-nicotinate complex","volume":"120","author":"Abdel-Mohsen","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"24","key":"10.1016\/j.jinorgbio.2026.113359_bb0105","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1039\/D5QI01687H","article-title":"Highly active superoxide dismutase mimic: pyridine carboxamide-based copper (ii) complexes","volume":"12","author":"Di\u00f3szegi","year":"2025","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.actbio.2016.02.005","article-title":"CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release","volume":"35","author":"Lin","year":"2016","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0115","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113359_bb0120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113359_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00622409","article-title":"Perchlorates of Cu (I) complexes with some pyridine derivatives","volume":"63","author":"Goher","year":"1976","journal-title":"Naturwissenschaften"},{"issue":"20","key":"10.1016\/j.jinorgbio.2026.113359_bb0135","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/jnci\/86.20.1517","article-title":"Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design","volume":"86","author":"Chou","year":"1994","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113359_bb0140","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s13346-024-01648-0","article-title":"A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer","volume":"15","author":"Bisht","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113359_bb0150","first-page":"H1508","article-title":"Chemotherapy-induced cardiotoxicity in breast cancer: mechanisms, diagnostic advances, and emerging protective strategies","volume":"329","author":"Ndzie Noah","year":"2025","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0155","first-page":"E036","article-title":"Multidimensional perspectives on cancer therapy-induced cardiotoxicity: characteristics, mechanisms, biomarkers, psychological stress effects, and treatment progress","volume":"3","author":"Chen","year":"2025","journal-title":"Cancer Pathog. Ther."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113359_bb0160","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00125-012-2475-7","article-title":"Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)","volume":"55","author":"Barlow","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0165","article-title":"Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00775-014-1219-1","article-title":"L-ornithine Schiff base\u2013copper and\u2013cadmium complexes as new proteasome inhibitors and apoptosis inducers in human cancer cells","volume":"20","author":"Zhang","year":"2015","journal-title":"JBIC J. Biol. Inorg. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jinorgbio.2026.113359_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0162-0134(01)00371-3","article-title":"Synthesis, characterization and biological activity of two new polymeric copper (II) complexes with alpha-ketoglutaric acid thiosemicarbazone","volume":"89","author":"Belicchi","year":"2002","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8494031","article-title":"Nuclear imaging study of the pharmacodynamic effects of Debio 1143, an antagonist of multiple inhibitor of apoptosis proteins (IAPs), in a triple-negative breast cancer model","volume":"2018","author":"Bellaye","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113359_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0190","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1074\/jbc.M109.070037","article-title":"Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death","volume":"285","author":"Kobayashi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.advms.2018.08.014","article-title":"Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells","volume":"64","author":"Abdel-Mohsen","year":"2019","journal-title":"Adv. Med. Sci."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113359_bb0200","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/molecules22071106","article-title":"Newly synthesized doxorubicin complexes with selected metals\u2014synthesis, structure and anti-breast cancer activity","volume":"22","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2017","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113359_bb0205","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113359_bb0210","article-title":"Rapamycin, an mTOR inhibitor, induced apoptosis via independent mitochondrial and death receptor pathway in retinoblastoma Y79 cell","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejmech.2016.02.055","article-title":"Copper complexes based on chiral Schiff-base ligands: DNA\/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis","volume":"114","author":"Zhou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113359_bb0220","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3892\/or.2015.4146","article-title":"The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth","volume":"34","author":"Wang","year":"2015","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113359_bb0225","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s11095-007-9413-2","article-title":"Mechanism of UVA-dependent DNA damage induced by an antitumor drug dacarbazine in relation to its photogenotoxicity","volume":"25","author":"Iwamoto","year":"2008","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113359_bb0230","first-page":"2643","article-title":"Oxidative DNA damage induced by pirarubicin, an anthracycline anticancer agent, in the presence of copper (II)","volume":"38","author":"Mizutani","year":"2018","journal-title":"Anticancer Res."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113359_bb0235","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1074\/mcp.RA118.000652","article-title":"Doxorubicin-induced DNA damage causes extensive ubiquitination of ribosomal proteins associated with a decrease in protein translation","volume":"17","author":"Halim","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"issue":"35","key":"10.1016\/j.jinorgbio.2026.113359_bb0240","doi-asserted-by":"crossref","first-page":"15591","DOI":"10.1039\/C5DT00450K","article-title":"Enhancement in intramolecular interactions and in vitro biological activity of a tripodal tetradentate system upon complexation","volume":"44","author":"Tyagi","year":"2015","journal-title":"Dalton Trans."},{"issue":"1000190","key":"10.1016\/j.jinorgbio.2026.113359_bb0245","article-title":"Alteration in the doxorubicin-induced DNA damage in cultured V79 cells by Aegle marmelos (L.) Correa (Bael): a comet assay study","volume":"2","author":"Jagetia","year":"2015","journal-title":"Int. J. Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113359_bb0250","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s13277-013-0848-2","article-title":"Prognostic value of survivin expression in breast cancer patients: a meta-analysis","volume":"34","author":"Song","year":"2013","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113359_bb0255","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10549-016-3961-2","article-title":"BIRC5 (survivin): a pejorative prognostic marker in stage II\/III breast cancer with no response to neoadjuvant chemotherapy","volume":"159","author":"Hamy","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.jinorgbio.2026.113359_bb0260","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.drudis.2017.05.009","article-title":"Targeting survivin for therapeutic discovery: past, present, and future promises","volume":"22","author":"Peery","year":"2017","journal-title":"Drug discovery today"},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113359_bb0265","first-page":"1043","article-title":"Inhibition of autophagy increases proliferation inhibition and apoptosis induced by the PI3K\/mTOR inhibitor NVP-BEZ235 in breast cancer cells","volume":"61","author":"Ji","year":"2015","journal-title":"Clin. Lab."},{"issue":"7\u20138","key":"10.1016\/j.jinorgbio.2026.113359_bb0270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10495-019-01547-7","article-title":"Copper-imidazo [1, 2-a] pyridines induce intrinsic apoptosis and modulate the expression of mutated p53, haem-oxygenase-1 and apoptotic inhibitory proteins in HT-29 colorectal cancer cells","volume":"24","author":"Harmse","year":"2019","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113359_bb0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmed.2008.02.002","article-title":"Immunogenicity of anthracyclines: moving towards more personalized medicine","volume":"14","author":"Apetoh","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113359_bb0280","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1408747","article-title":"Blockade of tumor-expressed PD-1 promotes lung cancer growth","volume":"7","author":"Du","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0285","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3389\/fimmu.2018.01774","article-title":"Cancer cell-intrinsic PD-1 and implications in combinatorial immunotherapy","volume":"9","author":"Yao","year":"2018","journal-title":"Front. Immunol."},{"issue":"163","key":"10.1016\/j.jinorgbio.2026.113359_bb0290","first-page":"2","article-title":"An indigenous plant bael (Aegle marmelos (L.) Correa) extract protects against the doxorubicin-induced cardiotoxicity in mice","volume":"4","author":"Jagetia","year":"2015","journal-title":"Biochem. Physiol."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113359_bb0295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopha.2008.01.015","article-title":"A pioneer study on the anti-ulcer activities of copper nicotinate complex [CuCl (HNA) 2] in experimental gastric ulcer induced by aspirin-pyloris ligation model (Shay model)","volume":"63","author":"Tuorkey","year":"2009","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113359_bb0300","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/01913123.2012.685687","article-title":"Time-dependent morphological and biochemical changes following cutaneous thermal burn injury and their modulation by copper nicotinate complex: an animal model","volume":"36","author":"Nassar","year":"2012","journal-title":"Ultrastruct. Pathol."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113359_bb0305","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.3390\/molecules13123040","article-title":"Copper complexes of nicotinic-aromatic carboxylic acids as superoxide dismutase mimetics","volume":"13","author":"Suksrichavalit","year":"2008","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113359_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31939-9","article-title":"Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells","volume":"8","author":"Taymaz-Nikerel","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113359_bb0315","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10534-017-0059-1","article-title":"Two mTOR inhibitors, rapamycin and Torin 1, differentially regulate iron-induced generation of mitochondrial ROS","volume":"30","author":"Huang","year":"2017","journal-title":"BioMetals"},{"key":"10.1016\/j.jinorgbio.2026.113359_bb0320","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/956792","article-title":"Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants","volume":"2013","author":"Poljsak","year":"2013","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426001480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426001480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:13:15Z","timestamp":1780665195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013426001480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":64,"alternative-id":["S0162013426001480"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113359","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copper (I) nicotinate complex potentiates chemotherapy-induced apoptosis in HCC-1806 triple negative breast cancer cells: An in vitro study","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113359"}}